An exploratory study to assess the RSV titer in healthy volunteers as guidance for the main study

Completed

• Conditions: common cold; RSV infection; 10024970

• Registration Number: NL-OMON44515
• Lead Sponsor: Intravacc

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

1.Healthy male or female subjects, 18-45 years of age, inclusive;
2.Signed informed consent prior to any study-mandated procedure
3. Has the ability to communicate well with the Investigator in the Dutch language

Exclusion Criteria

1. Immune-compromised individuals (known or expected immune deficiency, disease or use of medication that may affect the immune system);
2. Chronic airway diseases;
3. Airway infection / common cold within 14 days prior to blood sample collection;
4. Hay fever or other allergies that involve the airways;
5. Blood donation would result in loss of blood outside the limits of the national blood bank (>500 mL within 90 days.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Virus neutralization titer levels against RSV</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>